Evidence for the involvement of JAK/STAT pathway in the signaling mechanism of interleukin-17

被引:95
作者
Subramaniam, SV [1 ]
Cooper, RS [1 ]
Adunyah, SE [1 ]
机构
[1] Meharry Med Coll, Dept Biochem, Nashville, TN 37208 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1006/bbrc.1999.1156
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Interleukin-17 is a T-cell-derived pro-inflammatory cytokine, exhibiting multiple biological activities in a variety of cells and believed to fine tune all general phases of hematopoietic response. However, the signaling mechanism of this novel cytokine remains unknown. Here, we report for the first time that the early signaling events triggered by interleukin-17 involve tyrosine phosphorylation of several members of the JAK and STAT proteins in human U937 monocytic leukemia cells. Immunoprecipitation with specific antibodies followed by Western blot analysis with antiphosphotyrosine antibody has shown that in U937 cells, interleukin-17 induces time-dependent stimulation of tyrosine phosphorylation of JAK 1, 2 and 3, Tyk 2 and STAT 1, 2, 3 and 4 within 0.5 to 30 min. Interleukin-17-mediated tyrosine phosphorylation of these proteins strongly suggests that the JAK/STAT signaling pathway may play a major role in transducing signals from interleukin-17 receptors to the nucleus. (C) 1999 Academic Press.
引用
收藏
页码:14 / 19
页数:6
相关论文
共 35 条
[1]   Interleukin-2 induces tyrosine phosphorylation of SHP-2 through IL-2 receptor beta chain [J].
Adachi, M ;
Ishino, M ;
Torigoe, T ;
Minami, Y ;
Matozaki, T ;
Miyazaki, T ;
Taniguchi, T ;
Hinoda, Y ;
Imai, K .
ONCOGENE, 1997, 14 (13) :1629-1633
[2]   Granulocyte-macrophage colony-stimulating factor-activated signaling pathways in human neutrophils - Selective activation of Jak2, Stat3, and Stat5B [J].
Al-Shami, A ;
Mahanna, W ;
Naccache, PH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (02) :1058-1063
[3]  
Albanesi C, 1999, J IMMUNOL, V162, P494
[4]   Erythropoietin and interleukin-3 activate tyrosine phosphorylation of CBL and association with CRK adaptor proteins [J].
Barber, DL ;
Mason, JM ;
Fukazawa, T ;
Reedquist, KA ;
Druker, BJ ;
Band, H ;
DAndrea, AD .
BLOOD, 1997, 89 (09) :3166-3174
[5]   Interferon-beta interrupts interleukin-6-dependent signaling events in myeloma cells [J].
Berger, LC ;
Hawley, RG .
BLOOD, 1997, 89 (01) :261-271
[6]   Requirement for JAK2 in erythropoietin-induced signalling pathways [J].
Bittorf, T ;
Jaster, R ;
Ludtke, B ;
Kamper, B ;
Brock, J .
CELLULAR SIGNALLING, 1997, 9 (01) :85-89
[7]   Is interleukin 17, an inducible cytokine that stimulates production of other cytokines, merely a redundant player in a sea of other biomolecules? [J].
Broxmeyer, HE .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (06) :2411-2415
[8]   Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl [J].
Carlesso, N ;
Frank, DA ;
Griffin, JD .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (03) :811-820
[9]  
Fossiez F, 1998, Int Rev Immunol, V16, P541, DOI 10.3109/08830189809043008
[10]   T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines [J].
Fossiez, F ;
Djossou, O ;
Chomarat, P ;
FloresRomo, L ;
AitYahia, S ;
Maat, C ;
Pin, JJ ;
Garrone, P ;
Garcia, E ;
Saeland, S ;
Blanchard, D ;
Gaillard, C ;
DasMahapatra, B ;
Rouvier, E ;
Golstein, P ;
Banchereau, J ;
Lebecque, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (06) :2593-2603